Finolex Industries Q4 Results Review - Healthy Volume Growth Supported Earnings: IDBI Capital

IDBI Capital Report

Finolex Industries Ltd.’s Q4 FY24 result was in-line with our estimate on net sales front, while margins were beat to our forecast. The company reported healthy volume growth in Q4, which off-set decline in blended realisation.

The management expects the agro segment demand to be in higher single digit and high double digit in non-agro segment. Net sales was up by 8.3% YoY to Rs 12.3 billion, while Ebitda came in at Rs 2 billion, lower by 3.9% YoY.

Finolex Industries reported adjusted net profit of Rs 1.6 billion, marginally down by 1% over Q4 FY23. The company’s focus on increasing share on non-agri products to 50% by FY27E bodes well for overall earnings growth in long term.

We have increased our net sales/profit afer tax estimates by 2.8%/0.8% and 18%/13% over FY25E/FY26E respectively.

Maintain Hold with a target price of Rs 282 (earlier Rs 219) assigning 25 times PER on FY26E.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.